Severity
Moderate
FDA Drug recall · Reported July 13, 2022
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Wedgewood Village Pharmacy, LLC recalled Boric Acid 600 mg capsules, 14 capsules per box, Qty: 1, Wedgewood Village Pharmacy LLC, … - a moderate-severity action.
Boric Acid 600 mg capsules, 14 capsules per box, Qty: 1, Wedgewood Village Pharmacy LLC, … was recalled by Wedgewood Village Pharmacy, LLC in July 13, 2022. Reason: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection. Check the official notice for the remedy. Verify recall #D-1183-2022 with the FDA Drug before acting.
The recall
Wedgewood Village Pharmacy, LLC issued this moderate-severity FDA Drug recall-Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection.
Sourced from official FDA Drug enforcement records. Verify recall #D-1183-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1183-2022) was formally reported on July 13, 2022, with the manufacturer initiating the action on June 10, 2022. It is classified under Moderate severity (Class II), with a current status of Terminated. Wedgewood Village Pharmacy, LLC is listed as the recalling firm, operating out of Swedesboro, NJ. Federal records list the affected scope as 1 box.
The documented reason for this recall is: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection Distribution data in the federal record shows the product reached: Products were distributed nationwide in the USA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1 box
Related Recalls
6
5 from same agency
Boric Acid 600 mg capsules, 14 capsules per box, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Drive, Ste 200, Swedesboro, NJ 08085
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1183-2022 |
| Date reported | July 13, 2022 |
| Date initiated | June 10, 2022 |
| Recalling firm | Wedgewood Village Pharmacy, LLC |
| Firm location | Swedesboro, NJ |
| Affected scope | 1 box |
| Distribution | Products were distributed nationwide in the USA. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported July 13, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.